KLF10 antibody | antibody review based on formal publications (original) (raw)

This is a Validated Antibody Database (VAD) review about human KLF10, based on 4 published articles (read how Labome selects the articles), using KLF10 antibody in all methods. It is aimed to help Labome visitors find the most suited KLF10 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.

1. Zou Z, Chai M, Guo F, Fu X, Lan Y, Cao S, et al. MicroRNA-126 engineered muscle-derived stem cells attenuates cavernosa injury-induced erectile dysfunction in rats. Aging (Albany NY). 2021;13:14399-14415 pubmed publisher
2. Chen F, Xu B, Li J, Yang X, Gu J, Yao X, et al. Hypoxic tumour cell-derived exosomal miR-340-5p promotes radioresistance of oesophageal squamous cell carcinoma via KLF10. J Exp Clin Cancer Res. 2021;40:38 pubmed publisher
3. Li H, Yang F, Hu A, Wang X, Fang E, Chen Y, et al. Therapeutic targeting of circ-CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression. EMBO Mol Med. 2019;11:e10835 pubmed publisher
4. Lin C, Hsu Y, Huang Y, Shih Y, Wang C, Chiang W, et al. A KDM6A-KLF10 reinforcing feedback mechanism aggravates diabetic podocyte dysfunction. EMBO Mol Med. 2019;11: pubmed publisher